Table of Contents

company-logo

Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. It focuses on the therapeutic areas comprising oncology, hematology, rheumatology, auto-immune diseases, and allergy. The company's primary products are Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B; and Rupall, a prescription allergy medication. Its products portfolio also includes Treosulfan, a bifunctional alkylating agent for allogeneic hematopoietic stem cell transplantation; Trispan, a triamcinolone hexacetonide injectable suspension; and Gleolan, an optical imaging agent indicates for patients with glioma symptoms. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. is based in Bolton, Canada.

Medexus Pharmaceuticals Dividend Announcement

• Medexus Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Medexus Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Medexus Pharmaceuticals Dividend History

Medexus Pharmaceuticals Dividend Yield

Medexus Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Medexus Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Medexus Pharmaceuticals Financial Ratios

P/E ratio22.60
PEG ratio0.23
P/B ratio1.58
ROE7.33%
Payout ratio0.00%
Current ratio1.01
Quick ratio0.41
Cash Ratio0.11

Medexus Pharmaceuticals Dividend FAQ

Does Medexus Pharmaceuticals stock pay dividends?
Medexus Pharmaceuticals does not currently pay dividends to its shareholders.
Has Medexus Pharmaceuticals ever paid a dividend?
No, Medexus Pharmaceuticals has no a history of paying dividends to its shareholders. Medexus Pharmaceuticals is not known for its dividend payments.
Why doesn't Medexus Pharmaceuticals pay dividends?
There are several potential reasons why Medexus Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Medexus Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Medexus Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Medexus Pharmaceuticals a dividend aristocrat?
Medexus Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Medexus Pharmaceuticals a dividend king?
Medexus Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Medexus Pharmaceuticals a dividend stock?
No, Medexus Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Medexus Pharmaceuticals stocks?
To buy Medexus Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Medexus Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.